Elanco Animal Health Incorporated reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 1,028 million compared to USD 1,131 million a year ago. Net loss was USD 49 million compared to USD 104 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.21 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to USD 0.21 a year ago.
For the nine months, sales was USD 3,430 million compared to USD 3,652 million a year ago. Net loss was USD 23 million compared to USD 375 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.77 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.77 a year ago.